Erythropoietin (EPO) is upregulated by hypoxia and causes proliferation and differentiation
of erythroid progenitors in the bone marrow through inhibition of apoptosis. EPO receptors …

Diabetes is the pandemic disease of the modern era, with 10% of these patients having type
1 diabetes mellitus. Despite the prevalence, morbidities, and associated financial burden …

Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion
in the mouse kidney in vivo. Background Erythropoietin (EPO) is a potent stimulator of …

Background Research suggests that increasing neighbourhood social cohesion can prevent
mental health problems, including depression and anxiety. However, it is unknown whether …

The haematopoietic factor erythropoietin (EPO) has recently been recognized to play a
physiological role in the brain and other tissues. The EPO receptor is present in the …

Background: Coronary artery calcification measured by electron-beam computerized
tomography (EBCT) correlates with plaque burden and vessel stenosis and is predictive of …

Recently, erythropoietin was shown to have both hematopoietic as well as tissue‐protective
properties. Erythropoietin (EPO) had a protective effect in animal models of cerebral …

The gap between supply and demand in kidney transplantation has led to increased use of
marginal kidneys; however, kidneys with acute kidney injury are often declined/discarded …

Here we investigate the effects of erythropoietin (EPO) on the tissue/organ injury caused by
hemorrhagic shock (HS), endotoxic shock, and regional myocardial ischemia and …

Sarcoidosis is a chronic relapsing multi-systemic disorder characterized by the development
of non-caseating granulomas. Granulomatous tubulo-interstitial nephritis is an uncommon …